This notion is strongly supported by findings of significantly decreased testosterone and enhanced LH and FSH levels, which parallel the progression of CKD, which failed to correct after human chorionic gonadotropin (hCG) administration both in uremic rats and humans [24]. Here, BRD2 is linked to chronic kidney disease.